Literature DB >> 35368369

Bactericidal and fungicidal activities of novel ProtecTeaV formulations - alcohol-based hand hygiene and surface disinfectant prototypes containing epigallocatechin-3-gallate-palmitate (EC16).

Douglas Dickinson1, Melissa Del Tufo1, Emma Liu2, Xueling Shao1, Stephen Hsu1,2.   

Abstract

Objective: Currently used alcohol-based hand sanitizers and surgical hand rubs are not effective against alcohol-resistant microorganisms. We reported previously that nontoxic antioxidant food additive compounds derived from green tea polyphenols, particularly epigallocatechin-3-gallate-palmitate (EC16), are suitable in alcohol formulations to effectively inactivate nonenveloped viruses and bacterial spores. However, whether EC16 influences the bactericidal and fungicidal activity of alcohol is not clear. The objective of the current study was to determine the bactericidal and fungicidal activities of ProtecTeaV hand sanitizer and surface spray prototypes containing EC16.
Methods: The prototypes were tested according to the guidelines from the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA).
Results: As expected, EC16 did not reduce the bactericidal and fungicidal activities of ethanol. The hand sanitizer gel formulation was equally effective as 70% ethanol and met the tested standard, and the surface spray prototype met the EPA performance standard. Conclusions: EC16 can be combined with ethanol without reducing antibacterial or antifungal activity, and the ProtecTeaV prototypes could be further developed into novel hand hygiene and surface disinfectant products with virucidal, bactericidal, fungicidal and sporicidal activities.

Entities:  

Keywords:  EGCG-palmitate; bactericidal; fungicidal; green tea; hand hygiene; surface disinfectant

Year:  2021        PMID: 35368369      PMCID: PMC8975254          DOI: 10.33425/2639-9458.1135

Source DB:  PubMed          Journal:  Microbiol Infect Dis        ISSN: 2639-9458


  1 in total

Review 1.  Compounds Derived from Epigallocatechin-3-Gallate (EGCG) as a Novel Approach to the Prevention of Viral Infections.

Authors:  Stephen Hsu
Journal:  Inflamm Allergy Drug Targets       Date:  2015
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.